Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery

Journal of Cardiac Surgery

Volumn 23, Issue 3, 2008, Pages 209-215

  Filion, Kristian B ^a,b   Pilote, Louise ^a,b   Rahme, Elham ^a,b   Eisenberg, Mark J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; METOPROLOL; SIMVASTATIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PHARMACEUTICAL CARE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS;

EID: 42549145348     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2008.00596.x     Document Type: Article

References (42)

1. Auerbach AD, Goldman L : Beta-blockers and reduction of cardiac events in noncardiac surgery: Scientific review. JAMA 2002 287 : 1435 1444.
2. Mangano DT, Layug EL, Wallace A, et al : Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996 335 : 1713 1720.
3. Poldermans D, Boersma E, Bax JJ, et al : The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999 341 : 1789 1794.
4. Poldermans D, Bax JJ, Kertai MD, et al : Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003 107 : 1848 1851.
5. Dacey LJ, Munoz JJ, Johnson ER, et al : Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000 70 : 1986 1990.
6. Rady MY, Ryan T : The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest 1998 114 : 487 494.
7. Dotani MI, Elnicki DM, Jain AC, et al : Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 2000 86 : 1128 1130, A6.
8. Ferguson TB Jr., Coombs LP, Peterson ED : Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002 287 : 2221 2227.
9. Mangano DT : Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002 347 : 1309 1317.
10. Srinivasan AK, Grayson AD, Pullan DM, et al : Effect of preoperative aspirin use in off-pump coronary artery bypass operations. Ann Thorac Surg 2003 76 : 41 45.
11. Oosterga M, Voors AA, Pinto YM, et al : Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). Quinapril on vascular ace and determinants of ischemia. Am J Cardiol 2001 87 (5 542 546.
12. Weightman WM, Gibbs NM, Sheminant MR, et al : Drug therapy before coronary artery surgery: Nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival. Anesth Analg 1999 88 (2 286 291.
13. U.S.Department Of Health And Human Services : Generic International Classification Of Diseases, 9th Revision, Clinical Modifications (ICD-9-CM), Hospital Version 2001. Reno, Nevada : Channel Publishing, 2000.
14. Azoulay A : The use of the transition cost accounting system to compare costs of treatment between Canada and The United States: Methodological issues based on the case of acute myocardial infarction. Montreal, Quebec, Canada, McGill University, 2001.
15. Eisenberg MJ, Filion KB, Azoulay A, et al : Outcomes and cost of coronary artery bypass graft surgery in The United States and Canada. Arch Intern Med 2005 165 : 1506 1513.
16. Transition Systems I : Transition I: A Functional Overview. 1989. Boston, Mass.
17. Antoniou J, Martineau PA, Filion KB, et al : In-hospital cost of total hip arthroplasty in Canada and The United States. J Bone Joint Surg Am 2004 86-A : 2435 2439.
18. Canadian Institute For Health Information : Quality assurance processes applied to the discharge abstract and hospital morbidity databases. 2002. Ottawa, Ontario, Canadian Institute For Health Information.
19. Canadian Institute For Health Information : Discharge Abstract Database data quality re-abstraction study. 2002. Ottawa, Ontario, Canadian Institute For Health Information.
20. Austin PC, Daly PA, Tu JV : A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 2002 144 : 290 296.
21. Pitt B : Clinical trials of angiotensin receptor blockers in heart failure: What do we know and what will we learn? Am J Hypertens 2002 15 (1 Pt 2 22S 27S.
22. Eisenberg MJ, Okrainec K, Lefkovits J, et al : Medical therapy in patients undergoing percutaneous coronary intervention: Results from The ROSETTA registry. Can J Cardiol 2003 19 : 1009 1015.
23. Williams SC, Schmaltz SP, Morton DJ, et al : Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med 2005 353 : 255 264.
24. Brown NJ, Vaughan DE : Angiotensin-converting enzyme inhibitors. Circulation 1998 97 : 1411 1420.
25. Vane JR, Botting RM : The mechanism of action of aspirin. Thromb Res 2003 110 : 255 258.
26. Fuster V, Dyken ML, Vokonas PS, et al : Aspirin as a therapeutic agent in cardiovascular disease. Special writing group. Circulation 1993 87 (2 659 675.
27. Parmley WW : Optimum treatment of stable angina pectoris. Cardiovasc Drugs Ther 1998 12 (Suppl 1 105 110.
28. Greaves SC, Rutherford JD, Aranki SF, et al : Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J 1996 132 : 572 578.
29. Fleisher LA : Perioperative myocardial ischemia and infarction. Int Anesthesiol Clin 1992 30 : 1 17.
30. Plenge JK, Hernandez TL, Weil KM, et al : Simvastatin lowers C-reactive protein within 14 days: An effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002 106 : 1447 1452.
31. Vaughan CJ, Gotto AM, Jr., Basson CT : The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 2000 35 : 1 10.
32. Stevens RD, Burri H, Tramer MR : Pharmacologic myocardial protection in patients undergoing noncardiac surgery: A quantitative systematic review. Anesth Analg 2003 97 : 623 633.
33. Filion KB, Pilote L, Rahme E, et al : Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: A systematic review. Am Heart J 2007 154 : 407 414.
34. Coleman CI, Perkerson KA, Gillespie EL, et al : Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother 2004 38 : 2012 2016.
35. Ali IM, Sanalla AA, Clark V : Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardio-Thoracic Surg 1997 11 : 1154 1157.
36. Weisman SM, Graham DY : Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002 162 : 2197 2202.
37. Freemantle N, Cleland J, Young P, et al : Beta blockade after myocardial infarction: Systematic review and meta regression analysis. Brit Med J 1999 318 : 1730 1737.
38. Okrainec K, Platt R, Pilote L, et al : Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials. J Am Coll Cardiol 2005 45 : 177 184.
39. Yusuf S, Sleight P, Pogue J, et al : Effects of an angiotensin- converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 342 : 145 153.
40. Hampton JR : Secondary prevention of acute myocardial-infarction with beta-blocking-agents and calcium-antagonists. Am J Cardiol 1990 66 : C3 C8.
41. Hennekens CH, Dyken ML, Fuster V : Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from The American Heart Association. Circulation 1997 96 : 2751 2753.
42. Pfeffer MA, Braunwald E, Moye LA, et al : Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992 327 : 669 677.